D.E. Shaw & Co
BDSX icon

D.E. Shaw & Co’s Biodesix BDSX Stock Holding History

D.E. Shaw & Co’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,140
Closed -$39K – 5346
2022
Q1 		$39K Buy
1,140
+49
+4% +$3.2K ﹤0.01% 5201
2021
Q4 		$115K Buy
1,091
+277
+34% +$36.2K ﹤0.01% 5036
2021
Q3 		$134K Buy
814
+31
+4% +$5.88K ﹤0.01% 4662
2021
Q2 		$207K Buy
+783
New +$246K ﹤0.01% 4436

Other funds holding BDSX

BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co's BDSX Position: Q2 2022 in Review

D.E. Shaw & Co sold out of Biodesix (BDSX) in Q2 2022, closing a stake of 1,140 shares — an estimated $39K sold.

D.E. Shaw & Co first reported a position in BDSX in Q2 2021 and held it in 4 quarters. The position peaked at $207K in Q2 2021. 36 funds tracked by Wall St. Rank hold BDSX as of Q2 2022.

  • D.E. Shaw & Co reported no remaining Biodesix position as of Q2 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 1,140 Biodesix shares in Q2 2022, an estimated $39K.
  • D.E. Shaw & Co first reported a position in Biodesix in Q2 2021 and held it in 4 quarters.
  • D.E. Shaw & Co's Biodesix position peaked at $207K in Q2 2021.
  • 36 funds tracked by Wall St. Rank held Biodesix as of Q2 2022.

Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.